Health Condition 1: null- ASA I and II
Conditions
Interventions
Intervention1: Group R:-intraartular administration of ropivacaine 0.5% (20ML): In group R, 19 ml of 0.5% ropivacaine and 1 ml isotonic saline (total volume 20 ml) will be administered into the knee j
Sponsors
Government Medical College Jammu
Eligibility
Inclusion criteria
Inclusion criteria: After the ethic committeeâ??s approval, informed written consents were obtained from 108 patients, ASA physical status Iâ??II, age between 18 and 65, scheduled to undergo elective arthroscopic knee surgery.
Exclusion criteria
Exclusion criteria: Exclusion criteria included Patient refusal, any known allergy or contraindication to ropivacaine, or dexmedetomidine, pregnancy, lactating mothers and children, hepatic, renal or cardiopulmonary abnormality, long-term analgesic therapy, spinal cord deformities, bleeding diathesis, local skin site infections , and morbid obesity (body mass index > 35)..
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of effective analgesia will be measured from time of completion of surgery until first requirement of rescue analgesic.Timepoint: time of first analgesic request as the main primary variable | — |
Secondary
| Measure | Time frame |
|---|---|
| . VAS pain scores will be recorded at rest and on movement (90° flexion of the operated knee). total diclofenac and tramadol use during the first 24 postoperative hours will be also recordedTimepoint: ist 24 hours postoperatively | — |
Countries
India
Contacts
Public ContactRajesh Mahajan
GMC , JAMMU
Outcome results
None listed